{
  "schema": "pestle.medicine.v1",
  "url": "https://pestle.health/uk/flecainide",
  "country": "GB",
  "medicine": "Flecainide",
  "activeIngredient": "flecainide acetate",
  "source": {
    "type": "Patient information leaflet approved by the UK medicines regulator (MHRA)",
    "product": "Flecainide Acetate 100mg Tablets",
    "licenceNumber": "PL 16363/0326",
    "url": "https://mhraproducts4853.blob.core.windows.net/docs/e6a60375a64776ad51d346d4cdef7ae8e116ad2a",
    "leafletDate": "2026-06-19"
  },
  "checkedAgainstSource": "2026-11-19",
  "automatedCheck": {
    "sideEffectsListed": 98,
    "wordingFoundInLeaflet": 98,
    "notFound": 0
  },
  "reviewedBy": null,
  "whatItIsFor": "Flecainide is an anti-arrhythmic medicine that helps the heart pump normally again. It is used for certain serious heart rhythm problems, often shown by serious palpitations or a fast heartbeat, including when other medicines have not worked well or cannot be tolerated.",
  "keyFacts": [
    "Treatment is normally started under medical supervision, in hospital if necessary, and your doctor will set a personalised dose.",
    "Your doctor will check the level of flecainide in your blood and take regular ECGs (heart tracings) during treatment.",
    "Flecainide can itself cause a heart rhythm disorder, either worsening an existing arrhythmia or causing a new one.",
    "Dizziness and visual disturbances are the most commonly reported side effects, affecting about 15% of patients.",
    "Never stop taking it without your doctor knowing, because the arrhythmia will no longer be controlled as intended."
  ],
  "doNotTake": [
    "if you are allergic to flecainide or any of the other ingredients",
    "if you suffer from another heart condition, different from the one for which you are taking this medicine",
    "if you are also taking certain other antiarrhythmics (sodium channel blockers)",
    "if you know you have the genetic disease Brugada syndrome, shown by an abnormal ECG"
  ],
  "checkWithDoctorFirst": [
    "reduced liver function and/or reduced kidney function, as the level of flecainide in the blood may increase",
    "a permanent pacemaker or temporary pacing electrodes",
    "cardiac arrhythmias after heart surgery",
    "you have had a heart attack",
    "severe bradycardia or pronounced hypotension, which should be corrected before using flecainide",
    "elderly patients, as flecainide may be removed from the body more slowly and the dose may need adjusting",
    "certain rapid arrhythmias (AV reciprocation tachycardia), arrhythmias with WPW syndrome and other conduction pathway disorders, or occasional irregular heartbeat (paroxysmal fibrillation) with disabling symptoms: treatment should be under direct hospital or specialist supervision",
    "low or high potassium in the blood may influence the effect of flecainide and should be corrected before use",
    "taking activated charcoal (e.g. charcoal tablets) at the same time: only after talking to your doctor, as it affects how well flecainide works"
  ],
  "seriousSideEffects": [
    "unexplained jaundice (yellowing of the skin or whites of the eyes) or signs of liver dysfunction: it is advisable to stop flecainide (jaundice is Rare)"
  ],
  "sideEffectsByFrequency": [
    {
      "frequency": "Very common",
      "meaning": "More than 1 in 10 people",
      "effects": [
        "dizziness",
        "vertigo",
        "lightheadedness",
        "visual disturbances",
        "double vision",
        "blurred vision",
        "difficulty focusing"
      ]
    },
    {
      "frequency": "Common",
      "meaning": "Up to 1 in 10 people",
      "effects": [
        "more frequent occurrence of pre-existing arrhythmia (irregular heartbeat)",
        "shortness of breath",
        "weakness",
        "fatigue",
        "fever",
        "fluid in the tissues (edema)",
        "discomfort"
      ]
    },
    {
      "frequency": "Uncommon",
      "meaning": "Up to 1 in 100 people",
      "effects": [
        "decrease in red and white blood cells and platelets",
        "libido decreased",
        "depersonalisation/derealisation disorder",
        "euphoric mood",
        "increased dream activity",
        "apathy",
        "stupor",
        "erectile dysfunction",
        "eye irritation",
        "photophobia",
        "rapid involuntary movements of the eyes (nystagmus)",
        "hypertension",
        "bronchospasm",
        "irregular heart beat with increased heartbeat",
        "nausea",
        "vomiting",
        "constipation",
        "abdominal pain",
        "decreased appetite",
        "diarrhea",
        "flatulence",
        "dry mouth",
        "taste disturbances",
        "dermatitis exfoliative",
        "pain in upper abdomen, fullness (dyspepsia)",
        "allergic skin reactions such as rashes, hives and baldness",
        "production of abnormally large volumes of urine (polyuria)",
        "urinary retention",
        "swollen lips, tongue and mouth"
      ]
    },
    {
      "frequency": "Rare",
      "meaning": "Up to 1 in 1,000 people",
      "effects": [
        "seeing things that are not there (hallucinations)",
        "depression",
        "confusion",
        "anxiety",
        "memory loss (amnesia)",
        "insomnia",
        "tingling or numbness",
        "difficulty in controlling movements (ataxia)",
        "decrease of sensitivity",
        "increased sweating (hyperhidrosis)",
        "fainting (syncope)",
        "tremor",
        "flushing",
        "sleepiness",
        "headache",
        "nervous disorders e.g. in the arms and legs",
        "convulsions",
        "movement disorder (dyskinesia)",
        "ringing in the ears",
        "paresis",
        "speech disorder",
        "spinning sensation (vertigo)",
        "lung inflammation (pneumonia)",
        "elevated liver enzymes reversible on stopping treatment",
        "yellowing of the skin or whites of the eyes caused by liver or blood problems (jaundice)",
        "hives (urticaria)"
      ]
    },
    {
      "frequency": "Very rare",
      "meaning": "Up to 1 in 10,000 people",
      "effects": [
        "elevated levels of certain antibodies",
        "small cloudy spots on the eyeball",
        "sensitivity to sunlight"
      ]
    },
    {
      "frequency": "Not known",
      "meaning": "The leaflet says how often is not known",
      "effects": [
        "changes in electrocardiogram (ECG)",
        "increase in pacing threshold in patients with pacemakers or temporary pacing electrodes",
        "impairment of the conduction between the atria and ventricles of the heart (second or third degree atrioventricular block)",
        "stopped heart beat",
        "slower or faster heart beat",
        "loss of the heart's ability to pump enough blood to the body's tissues",
        "chest pain",
        "low blood pressure",
        "heart attack",
        "feeling your heart beat",
        "a pause in the normal cardiac rhythm (sinus arrest)",
        "appearance of a certain pre-existing heart disease (Brugada syndrome) which was not seen before the treatment with flecainide",
        "scarring of the lungs or lung disease (interstitial lung disease which causes breathlessness)",
        "liver disorder",
        "anorexia",
        "joint pain",
        "muscle pain"
      ]
    },
    {
      "frequency": "Not stated",
      "meaning": "The leaflet gives no frequency",
      "effects": [
        "heart rhythm disorder (existing cardiac arrhythmia may worsen or a new cardiac arrhythmia may develop)",
        "decrease in heart rate (bradycardia)",
        "increase in heart rate (tachycardia)",
        "palpitations",
        "cardiac arrest",
        "heart failure",
        "chest pain",
        "heart attack",
        "decreased blood pressure (hypotension)"
      ]
    }
  ],
  "otherMedicinesTheLeafletMentions": [
    "other sodium channel blockers (class I anti-arrhythmics) such as disopyramide and quinidine",
    "beta blockers such as propranolol",
    "amiodarone (for heart conditions)",
    "calcium channel blockers such as verapamil",
    "diuretics",
    "laxatives",
    "adrenal cortex hormones (corticosteroids)",
    "astemizole, mizolastine and terfenadine (medicines against allergies)",
    "ritonavir, lopinavar and indinavir (medicines to treat HIV infections)",
    "fluoxetine, paroxetine, reboxetine and certain other antidepressants named tricyclic antidepressants",
    "phenytoin, phenobarbital and carbamazepine (medicines against epilepsy)",
    "clozapine, haloperidol and risperidol (to treat psychotic disorders)",
    "quinine, quinidine and halofantrine (medicines against malaria)",
    "terbinafine (to treat fungal infections)",
    "cimetidine (an antacid)",
    "bupropion (anti-smoking medicine)",
    "digoxin",
    "activated charcoal (e.g. charcoal tablets)"
  ],
  "pregnancyAndBreastfeeding": "Flecainide should not be used in pregnancy unless clearly necessary, as it crosses the placenta, and the mother's blood levels should be monitored if it is used; tell your doctor as soon as you suspect you are pregnant or want to have children. Flecainide passes into breast milk, so nursing mothers should not breast-feed while taking it.",
  "howToTake": [
    "Take exactly as your doctor has told you; your doctor will prescribe a personalised dose and check with them or your pharmacist if unsure.",
    "Swallow the tablets with enough fluid such as water, on an empty stomach or at least one hour before meals; the daily dose is usually split up over the day.",
    "The recommended starting dose lies between 50 and 200 mg, and your doctor may increase it to a maximum of 400 mg a day; elderly patients should not exceed 300 mg daily and patients with a permanent pacemaker should not exceed 100 mg twice a day.",
    "Not for children under 12 years of age.",
    "If you miss a dose, take it when you remember unless it is almost time for the next one; never take a double dose."
  ],
  "notice": "Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets."
}